Quantum Pharmics Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QUANTUM PHARMICS
QUANTUM PHARMICS has sixty-three approved drugs.
Summary for Quantum Pharmics
| US Patents: | 0 |
| Tradenames: | 25 |
| Ingredients: | 23 |
| NDAs: | 63 |
Drugs and US Patents for Quantum Pharmics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quantum Pharmics | HALOPERIDOL | haloperidol | TABLET;ORAL | 071256-001 | Feb 17, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Quantum Pharmics | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 070921-001 | Dec 1, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Quantum Pharmics | CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | CAPSULE;ORAL | 071550-001 | Sep 12, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
